- Global Pharma News & Resources

Impact of Covid19 on Non-Small Cell Lung Cancer Market, Future Growth 2020-2026 | Siemens AG, Quest Diagnostics Inc., Mayo Medical Laboratories, etc

: New York, United States, 31-July-2020, (Via WiredRelease), (Reports and Data) – The Global Non-Small Cell Lung Cancer Market is forecast to reach USD 10.53 Billion by 2026, according to a new report by Reports and Data. Non-small cell lung cancer accounts for approximately 85% of all lung cancers. The rise in the number of people suffering from non-small cell lung cancer is one of the major factors driving the global non-small cell lung cancer drugs market growth. The risk factors such as air pollution, cigarette smoking, passive smoking, and occupational exposure are increasing the incidence of the disease globally.

One of the major drivers of the non-small cell lung cancer is the strong drug pipeline and recent drug approvals. The innovation of new drugs and their approvals for the treatment of the disease is anticipated to fuel the growth of the market. One of the challenges of the non-small cell lung cancer market is the high cost of treatment. The disease can be treated by chemotherapy, surgery, targeted therapies, radiation therapy, and immunotherapy, which is quite expensive. Thus, the high cost of the treatment will hamper the growth of the market.

Get Sample Copy with TOC of the Report to understand the structure of the complete report @

The COVID-19 impact:
Covid-19’s spread has affected manufacturing and construction activities worldwide. Logistic limitations and reconsiderations of the raw material requirements are becoming a problem for producers. The producers have relied on derived demand as an intermediate commodity to rationalize production. The pandemic’s economic impact on companies and financial markets is also not favorable. Stock market volatility and decreasing global growth are anticipated, which will affect the market.  The market has experienced a downturn over the weeks, which may continue over the next few months. The Asia Pacific is the most affected region by this pandemic, with China at the center of the outbreak. Most initiatives in multiple countries have changed to a temporary halt. Development, as well as supply, is put on hold, creating losses for suppliers, dealers and customers alike.

Key participants include

Siemens AG, Quest Diagnostics, Inc., Mayo Medical Laboratories, Laboratory Corporation of America Holdings, DaVita Healthcare Partners, SYNLAB International, Unilabs, Sonic Healthcare, Cerba HealthCare, and Abbott Laboratories, among others.

Any Query or Discount? Ask our Expert @

For the purpose of this report, Reports and Data have segmented into the global Non-Small Cell Lung Cancer market on the basis of type, propellants, application, and region:

Histology Outlook (Revenue, USD Billion; 2016-2026)

Squamous Cell CarcinomaLarge Cell CarcinomaAdenocarcinoma

Treatment Outlook (Revenue, USD Billion; 2016-2026)

SurgeryRadiationChemotherapyTargeted Therapy Drugs

Drug Class Outlook (Revenue, USD Billion; 2016-2026)

Angiogenesis InhibitorEpidermal Growth Factor Receptor BlockerKinase InhibitorMicrotubule StabilizerFolate AntimetabolitesPD-1/ PD-L1 Inhibitor

Regional Outlook (Revenue, USD Million; 2017-2027)

North America





Asia Pacific





Latin America


Inquiry before Buying @

Key insights of the report:

The report delivers key statistics on the current market status of the Non-Small Cell Lung Cancer manufacturers and is a reliable source of guidance and direction for the companies and individuals interested in the industry.

The report delivers an overview of the industry, including the basic definition, applications, the latest manufacturing technology, and others.

The report comprises of the company profile, product specifications, production capacity, production value, and market shares for the key competitors.

The market is further divided by company, by country, and by application/type for the competitive landscape analysis.

About Us:
Our in-house experts assist our clients with advice based on their proficiency in the market that helps them in creating a compendious database for the clients. Our team offers expert insights to clients to guide them through their business ventures. We put in rigorous efforts to keep our clientele satisfied and focus on fulfilling their demands to make sure that the end-product is what they desire. We excel in diverse fields of the market and with our services extending to competitive analysis, research and development analysis, and demand estimation among others, we can help you invest your funds in the most beneficial areas for research and development.

Contact Us:
John Watson
Head of Business Development
Reports and Data | Web:
Direct Line: +1-212-710-1370

This content has been published by MARKETYSERS GLOBAL CONSULTING LLP company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 03-Aug-2020